SCHEMBL29400313

SCHEMBL29400313

COC(=O)c1ccc2c(c1)NC(=O)/C2=C(/OC)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
ALOX5 P09917 1/20 0.46
TSHR P16473 1/20 0.45
GSK3B P49841 2/20 0.44
ROCK2 O75116 1/20 0.44
CSF1R P07333 1/20 0.44
KDR P35968 1/20 0.44
FLT3 P36888 1/20 0.44
GSK3A P49840 1/20 0.44
CDK5 Q00535 1/20 0.44
ROCK1 Q13464 1/20 0.44
SLK Q9H2G2 1/20 0.44
IRAK4 Q9NWZ3 1/20 0.44
PDPK1 O15530 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2277337 1.00 ALDH1A1 (0.48) ALDH1A1LMNAALOX5TSHRGSK3B
SCHEMBL29846133 1.00 ALDH1A1 (0.48) ALDH1A1LMNAALOX5TSHRGSK3B
SCHEMBL1361818 1.00 ALDH1A1 (0.48) ALDH1A1LMNAALOX5TSHRGSK3B
SCHEMBL15783957 1.00 ALDH1A1 (0.48) ALDH1A1LMNAALOX5TSHRGSK3B
SCHEMBL13560482 0.91 TDP1 (0.44) ALDH1A1ALOX5GSK3BROCK2CSF1R
SCHEMBL15784058 0.91 TDP1 (0.44) ALDH1A1ALOX5GSK3BROCK2CSF1R
SCHEMBL3772024 0.91 TDP1 (0.44) ALDH1A1ALOX5GSK3BROCK2CSF1R
SCHEMBL18423157 0.90 TDP1 (0.40) ALDH1A1LMNAALOX5TSHRGSK3B
SCHEMBL22437598 0.90 TDP1 (0.40) ALDH1A1LMNAALOX5TSHRGSK3B
SCHEMBL18215736 0.90 ALOX5 (0.45) ALDH1A1LMNAALOX5TSHRGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117214338-B Nidaminib ethanesulfonate cloth intermediate Z3Method for separating and detecting related substances in the same 重庆华邦制药有限公司 2025-05-23 CN disclosed
EP-3747864-B1 A METHOD FOR PREPARING METHYL (Z)-3-[[4-[METHYL[2-(4-METHYL-1-PIPERAZINYL)ACETYL]AMINO]PHENYL]AMINO]PHENYLMETHYLENE)-OXINDOLE-6-CARBOXYLATE (INTEDANIB, NINTEDANIB) Midas Pharma GmbH (DE) 2025-01-08 EP disclosed
CN-115703758-B Compounds used as kinase inhibitors, preparation method and application thereof 中国医学科学院药物研究所 2024-03-26 CN disclosed
CN-117214338-A Nidaminib mesylate intermediate Z 3 Method for separating and detecting related substances in the same 重庆华邦制药有限公司 2023-12-12 CN disclosed
CN-111465594-B Synthesis of 2-indolinones known as intermediates for the preparation of Nidamibu 费米有限公司 2023-11-07 CN disclosed
EP-3710427-B1 SYNTHESIS OF A 2-INDOLINONE DERIVATIVE KNOWN AS INTERMEDIATE FOR PREPARING NINTEDANIB FERMION OY (FI) 2023-03-08 EP disclosed
US-11261158-B2 Synthesis of 2-indolinone derivatives FERMION OY (FI) 2022-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11261158-B2 Synthesis of 2-indolinone derivatives AZI2, AANAT, IDO1 ALDH1A1 99/4885LMNA 2714/4885ALOX5 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.